KSHV infection and the pathogenesis of Kaposi's sarcoma.
暂无分享,去创建一个
[1] Frederick Y. Wu,et al. A novel viral mechanism for dysregulation of β-catenin in Kaposi's sarcoma–associated herpesvirus latency , 2003, Nature Medicine.
[2] D. Ganem,et al. Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis. , 2004, The Journal of clinical investigation.
[3] C. Boshoff,et al. Cyclin encoded by KS herpesvirus , 1996, Nature.
[4] S. Korsmeyer,et al. The apoptotic v-cyclin–CDK6 complex phosphorylates and inactivates Bcl-2 , 2000, Nature Cell Biology.
[5] S. Howell,et al. KSHV vFLIP binds to IKK-γ to activate IKK , 2003, Journal of Cell Science.
[6] C. Boshoff,et al. Degradation of p27Kip cdk inhibitor triggered by Kaposi's sarcoma virus cyclin–cdk6 complex , 1999, The EMBO journal.
[7] T. Schulz,et al. Latent Nuclear Antigen of Kaposi’s Sarcoma-Associated Herpesvirus Interacts with RING3, a Homolog of theDrosophila Female Sterile Homeotic (fsh) Gene , 1999, Journal of Virology.
[8] A. Krithivas,et al. Human Herpesvirus 8 LANA Interacts with Proteins of the mSin3 Corepressor Complex and Negatively Regulates Epstein-Barr Virus Gene Expression in Dually Infected PEL Cells , 2000, Journal of Virology.
[9] T. Piolot,et al. Close but Distinct Regions of Human Herpesvirus 8 Latency-Associated Nuclear Antigen 1 Are Responsible for Nuclear Targeting and Binding to Human Mitotic Chromosomes , 2001, Journal of Virology.
[10] Frederick Y. Wu,et al. Spindle Cell Conversion by Kaposi's Sarcoma-Associated Herpesvirus: Formation of Colonies and Plaques with Mixed Lytic and Latent Gene Expression in Infected Primary Dermal Microvascular Endothelial Cell Cultures , 2001, Journal of Virology.
[11] C. Lim,et al. Latency-associated Nuclear Antigen of Kaposi's Sarcoma-associated Herpesvirus Functionally Interacts with Heterochromatin Protein 1* , 2003, The Journal of Biological Chemistry.
[12] B. Chandran,et al. Activation of Kaposi's Sarcoma-Associated Herpesvirus (Human Herpesvirus 8) Lytic Replication by Human Cytomegalovirus , 2001, Journal of Virology.
[13] E. Cesarman,et al. Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation , 1997, Nature.
[14] E. Operskalski,et al. The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma–associated herpesvirus): Distribution of infection in KS risk groups and evidence for sexual transmission , 1996, Nature Medicine.
[15] Tong-Yuan Yang,et al. Transgenic Expression of the Chemokine Receptor Encoded by Human Herpesvirus 8 Induces an Angioproliferative Disease Resembling Kaposi's Sarcoma , 2000, The Journal of experimental medicine.
[16] L. Gradoville,et al. Open Reading Frame 50 Protein of Kaposi's Sarcoma-Associated Herpesvirus Directly Activates the Viral PAN and K12 Genes by Binding to Related Response Elements , 2002, Journal of Virology.
[17] D. Ganem,et al. The Kaposin B Protein of KSHV Activates the p38/MK2 Pathway and Stabilizes Cytokine mRNAs , 2005, Science.
[18] P. Volberding. Kaposi's sarcoma in AIDS. , 1989, Immunology series.
[19] D. Ganem,et al. The Latency-Associated Nuclear Antigen of Kaposi's Sarcoma-Associated Herpesvirus Permits Replication of Terminal Repeat-Containing Plasmids , 2003, Journal of Virology.
[20] Shou-Jiang Gao,et al. Productive Lytic Replication of a Recombinant Kaposi's Sarcoma-Associated Herpesvirus in Efficient Primary Infection of Primary Human Endothelial Cells , 2003, Journal of Virology.
[21] M. Tremblay,et al. Human herpesvirus 8 viral FLICE-inhibitory protein inhibits Fas-mediated apoptosis through binding and prevention of procaspase-8 maturation. , 2001, Journal of human virology.
[22] E. Jaffe,et al. Angiogenesis and hematopoiesis induced by Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6. , 1999, Blood.
[23] Shou-Jiang Gao,et al. Efficient Infection by a Recombinant Kaposi's Sarcoma-Associated Herpesvirus Cloned in a Bacterial Artificial Chromosome: Application for Genetic Analysis , 2002, Journal of Virology.
[24] D. Ganem,et al. Host Range of Kaposi's Sarcoma-Associated Herpesvirus in Cultured Cells , 2003, Journal of Virology.
[25] M. Eby,et al. The Human Herpes Virus 8-encoded Viral FLICE Inhibitory Protein Physically Associates with and Persistently Activates the IκB Kinase Complex* , 2002, The Journal of Biological Chemistry.
[26] G. Wood,et al. Evidence for the origin of Kaposi's sarcoma from lymphatic endothelium. , 1985, The American journal of pathology.
[27] T. Schulz,et al. Epidemiology of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8. , 1999, Advances in cancer research.
[28] M. Skobe,et al. Vascular endothelial growth factor-C (VEGF-C) and its receptors KDR and flt-4 are expressed in AIDS-associated Kaposi's sarcoma. , 1999, The Journal of investigative dermatology.
[29] D. Ganem,et al. Lytic KSHV infection inhibits host gene expression by accelerating global mRNA turnover. , 2004, Molecular cell.
[30] S. Henderson,et al. Kaposi sarcoma herpesvirus–induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma , 2004, Nature Genetics.
[31] E. van Marck,et al. Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[32] J. Regezi,et al. Human immunodeficiency virus-associated oral Kaposi's sarcoma. A heterogeneous cell population dominated by spindle-shaped endothelial cells. , 1993, The American journal of pathology.
[33] P. Moore,et al. Viral IL-6-Induced Cell Proliferation and Immune Evasion of Interferon Activity , 2002, Science.
[34] G. Hayward,et al. Kaposi's sarcoma-associated human herpesvirus-8 encodes homologues of macrophage inflammatory protein-1 and interleukin-6 , 1997, Nature Medicine.
[35] M. Mildner,et al. Expression of vascular endothelial growth factor receptor-3 and podoplanin suggests a lymphatic endothelial cell origin of Kaposi's sarcoma tumor cells. , 1999, Laboratory investigation; a journal of technical methods and pathology.
[36] E. Robertson,et al. The latency-associated nuclear antigen tethers the Kaposi's sarcoma-associated herpesvirus genome to host chromosomes in body cavity-based lymphoma cells. , 1999, Virology.
[37] J. Nicholas. Human herpesvirus-8-encoded signalling ligands and receptors. , 2003, Journal of biomedical science.
[38] B. Gazzard,et al. A comparison of regimens based on non-nucleoside reverse transcriptase inhibitors or protease inhibitors in preventing Kaposi's sarcoma , 2003, AIDS.
[39] M. Gaestel,et al. Is MK2 (mitogen-activated protein kinase-activated protein kinase 2) the key for understanding post-transcriptional regulation of gene expression? , 2001, Biochemical Society transactions.
[40] J. Gutkind,et al. The Kaposi's sarcoma-associated herpes virus G protein-coupled receptor up-regulates vascular endothelial growth factor expression and secretion through mitogen-activated protein kinase and p38 pathways acting on hypoxia-inducible factor 1alpha. , 2000, Cancer research.
[41] S. Mittnacht,et al. p16INK4a loss and sensitivity in KSHV associated primary effusion lymphoma , 2002, Oncogene.
[42] R. Sun,et al. Comparative Study of Regulation of RTA-Responsive Genes in Kaposi's Sarcoma-Associated Herpesvirus/Human Herpesvirus 8 , 2003, Journal of Virology.
[43] P. Murphy,et al. Kaposi’s Sarcoma-Associated Herpesvirus G Protein-Coupled Receptor Constitutively Activates NF-κB and Induces Proinflammatory Cytokine and Chemokine Production Via a C-Terminal Signaling Determinant , 2001, The Journal of Immunology.
[44] N. Bendsøe,et al. Human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) DNA in Kaposi's sarcoma lesions, AIDS Kaposi's sarcoma cell lines, endothelial Kaposi's sarcoma simulators, and the skin of immunosuppressed patients. , 1996, The American journal of pathology.
[45] M. McGrath,et al. Lytic growth of Kaposi's sarcoma–associated herpesvirus (human herpesvirus 8) in culture , 1996, Nature Medicine.
[46] D. Hanahan,et al. Transgenic mouse models of tumour angiogenesis: the angiogenic switch, its molecular controls, and prospects for preclinical therapeutic models. , 1996, European journal of cancer.
[47] M. Ballestas,et al. Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen 1 Mediates Episome Persistence through cis-Acting Terminal Repeat (TR) Sequence and Specifically Binds TR DNA , 2001, Journal of Virology.
[48] L. Hood,et al. Modulation of the NF-κB pathway by virally encoded Death Effector Domains-containing proteins , 1999, Oncogene.
[49] Ren Sun,et al. Human immunodeficiency virus type-1 activates lytic cycle replication of Kaposi's sarcoma-associated herpesvirus through induction of KSHV Rta. , 2002, Virology.
[50] B. Nathwani,et al. Evidence for multiclonality in multicentric Kaposi's sarcoma. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[51] B. Haar,et al. Monocytes in Kaposi's sarcoma lesions are productively infected by human herpesvirus 8 , 1997, Journal of virology.
[52] R. Schooley,et al. Relationship of human herpesvirus 8 peripheral blood virus load and Kaposi's sarcoma clinical stage , 2000, AIDS.
[53] J. Derisi,et al. Modulation of host gene expression by the constitutively active G protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus. , 2002, Cancer research.
[54] P. Moore,et al. Kaposi's Sarcoma-Associated Herpesvirus LANA2 Is a B-Cell-Specific Latent Viral Protein That Inhibits p53 , 2001, Journal of Virology.
[55] J. Gutkind,et al. Endothelial infection with KSHV genes in vivo reveals that vGPCR initiates Kaposi's sarcomagenesis and can promote the tumorigenic potential of viral latent genes. , 2003, Cancer cell.
[56] S. Mori,et al. Expression and localization of human herpesvirus 8-encoded proteins in primary effusion lymphoma, Kaposi's sarcoma, and multicentric Castleman's disease. , 2000, Virology.
[57] C. Atzler,et al. Signaling by human herpesvirus 8 kaposin A through direct membrane recruitment of cytohesin-1. , 2001, Molecular cell.
[58] D. Dittmer,et al. Inflammatory cytokines and the reactivation of Kaposi's sarcoma-associated herpesvirus lytic replication. , 2000, Virology.
[59] L. Szekely,et al. A Domain in the C-Terminal Region of Latency-Associated Nuclear Antigen 1 of Kaposi's Sarcoma-Associated Herpesvirus Affects Transcriptional Activation and Binding to Nuclear Heterochromatin , 2003, Journal of Virology.
[60] E. Cesarman,et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. , 1994, Science.
[61] P. Monini,et al. Biology of Kaposi's sarcoma. , 2001, European journal of cancer.
[62] L. Liotta,et al. Monoclonal origin of multicentric Kaposi's sarcoma lesions. , 1997, The New England journal of medicine.
[63] R. Leurs,et al. Kaposi's Sarcoma-Associated Herpesvirus-Encoded G Protein-Coupled Receptor ORF74 Constitutively Activates p44/p42 MAPK and Akt via Gi and Phospholipase C-Dependent Signaling Pathways , 2002, Journal of Virology.
[64] J. Regezi,et al. Oral Kaposi's sarcoma: a 10-year retrospective histopathologic study. , 1993, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[65] Lijun Wu,et al. A Complex Translational Program Generates Multiple Novel Proteins from the Latently Expressed Kaposin (K12) Locus of Kaposi’s Sarcoma-Associated Herpesvirus , 1999, Journal of Virology.
[66] P. Brown,et al. Modulation of Cellular and Viral Gene Expression by the Latency-Associated Nuclear Antigen of Kaposi's Sarcoma-Associated Herpesvirus , 2001, Journal of Virology.
[67] J. Brady,et al. Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Prolongs the Life Span of Primary Human Umbilical Vein Endothelial Cells , 2003, Journal of Virology.
[68] J. Tschopp,et al. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors , 1997, Nature.
[69] Jianhong Hu,et al. DNA Binding and Modulation of Gene Expression by the Latency-Associated Nuclear Antigen of Kaposi's Sarcoma-Associated Herpesvirus , 2001, Journal of Virology.
[70] J. Goedert,et al. Detection and quantification of Kaposi's sarcoma-associated herpesvirus to predict AIDS-associated Kaposi's sarcoma , 2003, AIDS.
[71] A. Srinivasan,et al. Human herpesvirus-8 encoded Kaposin: subcellular localization using immunofluorescence and biochemical approaches. , 2002, DNA and cell biology.
[72] E. Tschachler,et al. Kaposi's Sarcoma-Like Tumors in a Human Herpesvirus 8 ORF74 Transgenic Mouse , 2003, Journal of Virology.
[73] N. Jones,et al. Herpes viral cyclin/Cdk6 complexes evade inhibition by CDK inhibitor proteins , 1997, Nature.
[74] P. Stewart,et al. Elevated virus loads of Kaposi's sarcoma-associated human herpesvirus 8 predict Kaposi's sarcoma disease progression, but elevated levels of human immunodeficiency virus type 1 do not. , 2002, The Journal of infectious diseases.
[75] C. Boshoff,et al. Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma , 1995, The Lancet.
[76] A. Haase,et al. A Cluster of Latently Expressed Genes in Kaposi’s Sarcoma-Associated Herpesvirus , 1998, Journal of Virology.
[77] P. Moore,et al. Characterization and Cell Cycle Regulation of the Major Kaposi’s Sarcoma-Associated Herpesvirus (Human Herpesvirus 8) Latent Genes and Their Promoter , 1999, Journal of Virology.
[78] C. Boshoff,et al. The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma–E2F pathway and with the oncogene Hras transforms primary rat cells , 2000, Nature Medicine.
[79] Jianhong Hu,et al. Latency-associated Nuclear Antigen (LANA) Cooperatively Binds to Two Sites within the Terminal Repeat, and Both Sites Contribute to the Ability of LANA to Suppress Transcription and to Facilitate DNA Replication* , 2002, The Journal of Biological Chemistry.
[80] W. Hammerschmidt,et al. Spontaneous Activation of the Lytic Cycle in Cells Infected with a Recombinant Kaposi's Sarcoma-Associated Virus , 2001, Journal of Virology.
[81] P. Biberfeld,et al. The Inhibitor of Death Receptor Signaling, Flice-Inhibitory Protein Defines a New Class of Tumor Progression Factors , 1999, The Journal of experimental medicine.
[82] C. Lim,et al. Functional Dissection of Latency-Associated Nuclear Antigen 1 of Kaposi's Sarcoma-Associated Herpesvirus Involved in Latent DNA Replication and Transcription of Terminal Repeats of the Viral Genome , 2002, Journal of Virology.
[83] É. Oksenhendler,et al. Molecular analysis of clonality in Kaposi's sarcoma. , 1997, Journal of clinical pathology.
[84] Kaposi,et al. Idiopathisches multiples Pigmentsarkom der Haut , 1872, Archiv für Dermatologie und Syphilis.
[85] P. Pellett,et al. Risk factors for Kaposi's sarcoma in men seropositive for both human herpesvirus 8 and human immunodeficiency virus , 2003, AIDS.
[86] M. Dahiya,et al. Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Induces Expression of the Helix-Loop-Helix Protein Id-1 in Human Endothelial Cells , 2003, Journal of Virology.
[87] R. Gallo,et al. Absence of human herpesvirus 8 DNA sequences in neoplastic Kaposi's sarcoma cell lines. , 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[88] R. Sun,et al. A viral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[89] J. Brady,et al. Identification of Kaposin (Open Reading Frame K12) as a Human Herpesvirus 8 (Kaposi’s Sarcoma-Associated Herpesvirus) Transforming Gene , 1998, Journal of Virology.
[90] M. Corbellino,et al. Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. , 2000, The American journal of pathology.
[91] M. McMahon,et al. De Novo Infection and Serial Transmission of Kaposi's Sarcoma-Associated Herpesvirus in Cultured Endothelial Cells , 2002, Journal of Virology.
[92] M. Kaplan,et al. Human herpesvirus-like nucleic acid in various forms of Kaposi's sarcoma , 1995, The Lancet.
[93] E. Cesarman,et al. G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator , 1998, Nature.
[94] P. Moore,et al. Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and those without HIV infection. , 1995, The New England journal of medicine.
[95] P. Allavena,et al. The viral chemokine macrophage inflammatory protein-II is a selective Th2 chemoattractant. , 1998, Blood.
[96] A. Haase,et al. Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells , 1997, Journal of virology.
[97] Jianhong Hu,et al. The Latency-Associated Nuclear Antigen of Kaposi's Sarcoma-Associated Herpesvirus Supports Latent DNA Replication in Dividing Cells , 2002, Journal of Virology.
[98] D. Noonan,et al. KSHV sequences in biopsies and cultured spindle cells of epidemic, iatrogenic and Mediterranean forms of Kaposi's sarcoma. , 1996, Research in virology.
[99] E. Cesarman,et al. Inhibition of NF-kappaB induces apoptosis of KSHV-infected primary effusion lymphoma cells. , 2000, Blood.
[100] D. Ganem,et al. Highly Selective Escape from KSHV-mediated Host mRNA Shutoff and Its Implications for Viral Pathogenesis , 2004, The Journal of experimental medicine.
[101] E. Geras-Raaka,et al. Chemokines activate Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor in mammalian cells in culture. , 1998, The Journal of clinical investigation.
[102] M. Ballestas,et al. Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen. , 1999, Science.
[103] T. Veikkola,et al. Vascular Endothelial Growth Factor-C Stimulates the Migration and Proliferation of Kaposi’s Sarcoma Cells* , 1999, The Journal of Biological Chemistry.
[104] N. Jones,et al. The oncogenic potential of Kaposi's sarcoma-associated herpesvirus cyclin is exposed by p53 loss in vitro and in vivo. , 2002, Cancer cell.
[105] J. Phair,et al. KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma , 1996, Nature Medicine.
[106] D. Ganem,et al. Reactivation of Kaposi's sarcoma-associated herpesvirus infection from latency by expression of the ORF 50 transactivator, a homolog of the EBV R protein. , 1998, Virology.
[107] C. Boshoff,et al. Molecular Mimicry of Human Cytokine and Cytokine Response Pathway Genes by KSHV , 1996, Science.
[108] G. Nabel,et al. p53 inhibition by the LANA protein of KSHV protects against cell death , 1999, Nature.
[109] T. Veikkola,et al. Kaposi's sarcoma-associated herpesvirus-encoded v-cyclin triggers apoptosis in cells with high levels of cyclin-dependent kinase 6. , 1999, Cancer research.
[110] C. Boshoff,et al. The cyclin encoded by Kaposi's sarcoma-associated herpesvirus stimulates cdk6 to phosphorylate the retinoblastoma protein and histone H1 , 1997, Journal of virology.
[111] E. Tschachler,et al. Expression of HHV‐8 latency‐associated T0.7 RNA in spindle cells and endothelial cells of AIDS‐associated, classical and African Kaposi's sarcoma , 1997, International journal of cancer.
[112] C. Cockerell. Histopathological features of Kaposi's sarcoma in HIV infected individuals. , 1991, Cancer surveys.
[113] E. Cesarman,et al. Kaposi's sarcoma-associated herpesvirus contains G protein-coupled receptor and cyclin D homologs which are expressed in Kaposi's sarcoma and malignant lymphoma , 1996, Journal of virology.
[114] L. Szekely,et al. Latent nuclear antigen of Kaposi's sarcoma herpesvirus/human herpesvirus-8 induces and relocates RING3 to nuclear heterochromatin regions. , 2002, The Journal of general virology.
[115] S. Rafii,et al. Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus , 1998, Nature.
[116] L. Kaplan,et al. AIDS malignancies in the era of highly active antiretroviral therapy. , 2002, Oncology.
[117] F. Neipel,et al. Kaposi's sarcoma-associated herpesvirus encodes a functional cyclin , 1997, Journal of virology.
[118] F. Neipel,et al. Cell-homologous genes in the Kaposi's sarcoma-associated rhadinovirus human herpesvirus 8: determinants of its pathogenicity? , 1997, Journal of virology.
[119] S. Mahajan,et al. Carboxy Terminus of Human Herpesvirus 8 Latency-Associated Nuclear Antigen Mediates Dimerization, Transcriptional Repression, and Targeting to Nuclear Bodies , 2000, Journal of Virology.
[120] Jay W. Shin,et al. Lymphatic reprogramming of blood vascular endothelium by Kaposi sarcoma–associated herpesvirus , 2004, Nature Genetics.
[121] M. Stürzl,et al. Kaposi's sarcoma: a review of gene expression and ultrastructure of KS spindle cells in vivo. , 1992, AIDS research and human retroviruses.
[122] G. Hayward,et al. Patterns of Gene Expression and a Transactivation Function Exhibited by the vGCR (ORF74) Chemokine Receptor Protein of Kaposi's Sarcoma-Associated Herpesvirus , 2002, Journal of Virology.
[123] W. Zhong,et al. Restricted expression of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genes in Kaposi sarcoma. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[124] R. Sun,et al. Kaposi's sarcoma-associated herpesvirus encoded vFLIP induces cellular IL-6 expression: the role of the NF-κB and JNK/AP1 pathways , 2003, Oncogene.
[125] V. Beral,et al. Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection? , 1990, The Lancet.
[126] G. Shaw,et al. A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation , 1986, Cell.
[127] C. Boshoff,et al. Internal Ribosome Entry Site Regulates Translation of Kaposi's Sarcoma-Associated Herpesvirus FLICE Inhibitory Protein , 2001, Journal of Virology.
[128] B. Ensoli,et al. Kaposi's sarcoma: a result of the interplay among inflammatory cytokines, angiogenic factors and viral agents. , 1998, Cytokine & growth factor reviews.
[129] J. Russo,et al. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[130] S. Nakamura,et al. AIDS-Kaposi's sarcoma-derived cells express cytokines with autocrine and paracrine growth effects. , 1989, Science.
[131] G. Barillari,et al. Angiogenic Effects of Extracellular Human Immunodeficiency Virus Type 1 Tat Protein and Its Role in the Pathogenesis of AIDS-Associated Kaposi's Sarcoma , 2002, Clinical Microbiology Reviews.
[132] D. Ganem,et al. The biology of Kaposi's sarcoma. , 2001, Cancer treatment and research.
[133] L. Bieleski,et al. Kaposi's Sarcoma-Associated Herpesvirus vCyclin Open Reading Frame Contains an Internal Ribosome Entry Site , 2001, Journal of Virology.
[134] C. Boshoff,et al. Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells , 1995, Nature Medicine.
[135] J. Fallon,et al. The chemokine receptor CCR8 mediates human endothelial cell chemotaxis induced by I-309 and Kaposi sarcoma herpesvirus-encoded vMIP-I and by lipoprotein(a)-stimulated endothelial cell conditioned medium. , 2001, Blood.
[136] L. Chieco‐Bianchi,et al. Acquired immunodeficiency syndrome-related Kaposi's sarcoma regression after highly active antiretroviral therapy: biologic correlates of clinical outcome. , 2000, Journal of the National Cancer Institute. Monographs.
[137] S. Nakamura,et al. Angiogenic properties of Kaposi's sarcoma-derived cells after long-term culture in vitro. , 1988, Science.
[138] D. Ganem,et al. Mechanisms Governing Expression of the v-FLIP Gene of Kaposi's Sarcoma-Associated Herpesvirus , 2001, Journal of Virology.
[139] J. Harrington,et al. Repetitive strain injuries , 1997, The Lancet.
[140] P. Browning,et al. Human Immunodeficiency Virus Replication in a Primary Effusion Lymphoma Cell Line Stimulates Lytic-Phase Replication of Kaposi’s Sarcoma-Associated Herpesvirus , 1999, Journal of Virology.
[141] A. Haase,et al. Expression of the Open Reading Frame 74 (G-Protein-Coupled Receptor) Gene of Kaposi’s Sarcoma (KS)-Associated Herpesvirus: Implications for KS Pathogenesis , 1999, Journal of Virology.
[142] Chin‐Yun Lee,et al. Reciprocal Regulatory Interaction between Human Herpesvirus 8 and Human Immunodeficiency Virus Type 1* , 2001, The Journal of Biological Chemistry.
[143] C. Boshoff,et al. KSHV-encoded CC chemokine vMIP-III is a CCR4 agonist, stimulates angiogenesis, and selectively chemoattracts TH2 cells. , 2000, Blood.
[144] B. Gazzard,et al. Prospective Study of the Effects of Antiretroviral Therapy on Kaposi Sarcoma‐Associated Herpesvirus Infection in Patients With and Without Kaposi Sarcoma , 2002, Journal of acquired immune deficiency syndromes.
[145] C. Pellet,et al. Clinical and biological impact of antiretroviral therapy with protease inhibitors on HIV‐related Kaposi's sarcoma , 1998, AIDS.
[146] C. Buchrieser,et al. Monoclonality or oligoclonality of human herpesvirus 8 terminal repeat sequences in Kaposi's sarcoma and other diseases. , 2000, Journal of the National Cancer Institute.
[147] N. Jones,et al. Modulation of p27Kip1 levels by the cyclin encoded by Kaposi's sarcoma‐associated herpesvirus , 1999 .
[148] A. Palestine,et al. Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. Roche Ganciclovir Study Group. , 1999, The New England journal of medicine.
[149] T. Hirano,et al. AIDS Kaposi sarcoma-derived cells produce and respond to interleukin 6. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[150] J. Goedert,et al. Multicenter comparison of serologic assays and estimation of human herpesvirus 8 seroprevalence among US blood donors , 2003, Transfusion.
[151] R. Gray,et al. Adjuvant therapy for very young women with breast cancer: need for tailored treatments. , 2001, Journal of the National Cancer Institute. Monographs.
[152] M. Murphey-Corb,et al. Rhesus rhadinovirus infection in healthy and SIV‐infected macaques at Tulane National Primate Research Center , 2003, Journal of medical primatology.
[153] C. Lim,et al. Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) binds ATF4/CREB2 and inhibits its transcriptional activation activity. , 2000, The Journal of general virology.
[154] D R Hoover,et al. Kaposi's sarcoma-associated herpesvirus infection prior to onset of Kaposi's sarcoma , 1996, AIDS.
[155] Jeffrey N. Martin,et al. Sexual transmission and the natural history of human herpesvirus 8 infection. , 1998, The New England journal of medicine.
[156] R. Sun,et al. NF-κB Inhibits Gammaherpesvirus Lytic Replication , 2003, Journal of Virology.
[157] C. Wood,et al. Activation of HHV-8 by HIV-1 tat , 1997, The Lancet.
[158] M. Fujimuro,et al. Protein Interactions Targeting the Latency-Associated Nuclear Antigen of Kaposi's Sarcoma-Associated Herpesvirus to Cell Chromosomes , 2002, Journal of Virology.